# EDGAR Filing Document

**Accession Number:** 0000927761
**File Stem:** 0001654954-23-001483
**Filing Date:** 2023-2
**Character Count:** 5105
**Document Hash:** 35a8971311a6eb754024ac96657aca14
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001654954-23-001483.hdr.sgml**: 20230208

**ACCESSION NUMBER**: 0001654954-23-001483

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20230208

**ITEM INFORMATION**: Other Events

**FILED AS OF DATE**: 20230208

**DATE AS OF CHANGE**: 20230208

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MYMETICS CORP
- **CENTRAL INDEX KEY:** 0000927761
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **IRS NUMBER:** 251741849
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-25132
- **FILM NUMBER:** 23599983

**BUSINESS ADDRESS:**
- **STREET 1:** EUROPEAN EXECUTIVE OFFICE
- **STREET 2:** 4, ROUTE DE LA CORNICHE
- **CITY:** EPALINGES
- **STATE:** V8
- **ZIP:** CH-1066
- **BUSINESS PHONE:** 011-41-21-653-45-35

**MAIL ADDRESS:**
- **STREET 1:** EUROPEAN EXECUTIVE OFFICE
- **STREET 2:** 4, ROUTE DE LA CORNICHE
- **CITY:** EPALINGES
- **STATE:** V8
- **ZIP:** CH-1066

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ICHOR CORP
- **DATE OF NAME CHANGE:** 19970407

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PDG REMEDIATION INC
- **DATE OF NAME CHANGE:** 19940801

?xml version="1.0" encoding="utf-8"?mymx_8k.htm

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported): **February 8, 2023**

---

| |
|:---|
| **Mymetics Corporation** |
| (Exact name of registrant as specified in its charter) |

---

---

| | | |
|:---|:---|:---|
| **Delaware** | **000-25132** | **25-1741849** |
| (State of other jurisdiction<br>of incorporation) | (Commission<br>File Number) | (IRS Employer<br>Identification No.) |

---

---

| | |
|:---|:---|
| **Route de la Corniche 4 1066 Epalinges, Switzerland** | **NA** |
| (Address of principal executive offices) | (Zip Code) |

---

Registrant's telephone number, including area code: **+01141 21 653 45 35**

**<u>Not Applicable</u>**

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(g) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common Stock, $.01 par value | MYMX | OTCQB |

---

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 8.01 Other Events.**

Mymetics Corporation (the "Company") has been conducting a process to explore strategic alternatives to enhance shareholder value. The Board authorized management and its external advisors to initiate such a process, and it has been considering a broad range of strategic alternatives including a potential sale of part or all of the Company.

In connection therewith, the Company, through its external advisors, has requested bids (the "Bid Process") for any combination of assets (including but not limited to as a going concern), by February 24, 2023 at 5:00 pm ET (the "Bid Deadline"). To the extent the Company determines there are viable bids by or prior to the Bid Deadline, the Company anticipates pursuing those in due course. To the extent the Company determines there are no viable bids provided by or prior the Bid Deadline, the Company may consider other alternatives, including the wind up of its operations shortly after the Bid Deadline.

There can be no assurance that the Bid Process will result in a sale of part or all of the Company or other change or outcome.

The Company has retained Rock Creek Advisors as financial advisor and McDermott, Will & Emery LLP as legal counsel in connection with the Bid Process.

2<br>

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | MYMETICS CORPORATION | MYMETICS CORPORATION |
| Date: February 8, 2023 | By: | /s/ Ronald Kempers |
|  |  | Ronald Kempers |
|  |  | President and Chief Executive Officer |

---

3<br>